Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Obesity 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Overweight 1Non-alcoholic Fatty Liver Disease 1Neoplasms 1Infections 1Barrett Esophagus 1

Interventions

Metformin 2sultamicillin 1semaglutide 1Ursodeoxycholic Acid 1Tirzepatide 1Resistance Training 1Propofol 1Progestins 1Nutrition Assessment 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Hysteroscopy 1Exercise 1Exenatide 1Estrogen Replacement Therapy 1Docosahexaenoic Acids 1Cyproterone 1(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Overweight × Docosahexaenoic Acids × Clear all
NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Ain Shams University

Phase 4 Active not recruiting
200 enrolled
LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡